CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant Lab to promote collaborative ventures between Belmont's School of Pharmacy

and health care providers



    NASHVILLE, Tenn., July 1 /PRNewswire/ -- Cumberland Emerging
 Technologies, Inc. (CET) today announced that Belmont University has
 established the Belmont School of Pharmacy Department of Pharmaceutical
 Sciences Laboratory at the CET Life Sciences Center. The Life Sciences
 Center, which is located in downtown Nashville, provides lab and office
 space, equipment and infrastructure to early-stage biopharmaceutical
 ventures.
 
     (Photo: http://www.newscom.com/cgi-bin/prnh/20080701/CLTU108 )
 
     Belmont has leased the space to support research and service programs
 of its School of Pharmacy. The primary objective of the lab is to provide
 dosage form development, characterization and quality analysis. The school
 will work with the pharmaceutical industry and local and regional health
 care providers to meet previously unmet and emerging needs related to drug
 delivery.
 
     The work being performed at the Life Sciences Center is designed to
 help provide drug delivery solutions, which is unique to pharmacy practice
 and which, until now, has not played a major role in middle Tennessee's
 robust health care scene," said Dr. Andrew Webster, Chair and Professor of
 Pharmaceutical Sciences at Belmont's School of Pharmacy. "By partnering
 with CET, our faculty and students have access to a community of resources
 to advance research that will help drug developers bring their products to
 patients who need them most."
 
     "We are delighted to welcome Belmont School of Pharmacy to our growing
 roster of tenants at the Life Sciences Center," said A.J. Kazimi, Chief
 Executive Officer of Cumberland Pharmaceuticals and CET. "Partnering with
 outstanding academic research and training programs like this one is a key
 component of CET's strategy, and we look forward to providing laboratory
 and equipment infrastructure to support their promising research."
 
     Belmont's School of Pharmacy announced last week that it has received
 approval from The Accreditation Council for Pharmacy Education (ACPE) to
 seat its first class of 75 students for the 2008-09 academic year.
 
     Belmont University, host of the 2008 Town Hall Presidential Debate, is
 a fast-growing community of nearly 4,800 students who come from almost
 every state and more than 25 countries. Committed to being a leader among
 teaching universities, Belmont brings together the best of liberal arts and
 professional education in a Christian community of learning and service.
 Belmont's purpose is to help students explore their passions and develop
 their talents to meet the world's needs. With more than 75 areas of study,
 12 master's programs and three doctoral degrees, there is no limit to the
 ways Belmont University can expand an individual's horizon. For more
 information, visit www.belmont.edu.
 
     Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint
 initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University
 and the Tennessee Technology Development Corporation. The mission of CET is
 to bring biomedical technologies and products conceived at Vanderbilt and
 other regional research centers to the marketplace. CET helps manage the
 development and commercialization process for select projects, and provides
 expertise on intellectual property, regulatory, manufacturing and marketing
 issues that are critical to successful new biomedical products. CET's Life
 Sciences Center, located in Nashville, Tennessee, provides laboratory
 space, equipment and infrastructure to early-stage life sciences companies.
 
 
 

SOURCE Cumberland Emerging Technologies, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.